>> COVID variant gets put on the list
>> New insight into pain and poor sleep
>> Oral appliance for sleep apnea: the first step
The Med & Mic™ 11.29.23
A medical news blog post
from the author of “Scoop, MD”
COVID Variant Surges
The highly mutated COVID variant BA.2.86 accounts for 1 in 10 new COVID cases in the U.S.
Its prevalence is highest in the Northeast
Emergency department visits because of COVID have increased nationwide.
BA.2.86’s surge reflected in this week’s figures puts it on the CDC’s list as a standalone variant.
(Source: CBS News, A. Tin, 11.28.23)
Pain-Poor Sleep Link
In a mouse study, Harvard researchers have found that chronic sleep disruption reduces the levels of a neurotransmitter called NADA in the brain.
The decrease in NADA heightens the perception of pain.
NADA targets cannabinoid receptors in the brain.
(Source: New Atlas, M. Irving, 11.28.23)
New Sleep Apnea Device Cleared
The FDA has cleared (different from approved) the first oral device for obstructive sleep apnea.
The oral appliance therapy, used in conjunction with exercises, gradually repositions hard and soft tissues that define the airway.
In the clearance process, the FDA will evaluate safety and performance data for equivalence to existing products, such as pressurized air devices.
(Source: Reuters, P. Jain, 11.29.23)
Click the follow button to keep up on the medical news of the day.
For more about preparing for media interviews, read “Scoop, MD: the Doctor’s Guide to Media Interviews and Opportunities” on Amazon Kindle Vella.
Remember: this post is for informational purposes only and may not be the best fit for you and your personal situation. It shall not be construed as medical advice. The information and education provided here is not intended or implied to supplement or replace professional medical treatment, advice, and/or diagnosis, or the advice of your own physician. Always check with your own physician or medical professional before trying or implementing any information read here.